Browse our collection
This phase 3, randomized, placebo controlled trial evaluated the efficacy and safety of once weekly …
This editorial critiques the diagnostic thresholds for gestational diabetes mellitus (GDM) in light of the …
The BEST-CLI trial was a multicenter, randomized study evaluating surgical versus endovascular revascularization for chronic …
Retatrutide (LY3437943) is a triple agonist of the glucose-dependent insulinotropic polypeptide (GIP), glucagon like peptide …
This editorial reflects on two decades of the polypill concept originating with Wald and Law …
This editorial discusses the safety of testosterone-replacement therapy (TRT) in older men with hypogonadism, focusing …
This clinical image report describes a 58-year-old man with coronary artery disease who presented with …
A 68 year old man with type 2 diabetes presented with dysuria, hematuria, and passage …
This image-based case report describes a 64-year-old man with well-controlled rheumatoid arthritis who presented with …
This perspective article examines the Texas directive issued by Governor Greg Abbott in February 2022, …
This perspective emphasizes the urgent need to cultivate a new generation of clinician innovators who …
This clinical decision feature explores the management of hyperglycemia in a hospitalized 72 year old …
This perspective piece recounts the author's personal experience as a queer and trans individual seeking …
This review article examines the pathophysiology, clinical presentation, and management of spontaneous intracerebral hemorrhage (ICH), …
This article reviews emerging evidence challenging the perceived safety of artificial sweeteners, focusing on sucralose …
This clinical practice article reviews evidence based strategies for managing glycemia in children with type …
In this perspective piece, Dr. Howard Holtz highlights the critical need for effective communication and …
This observational study investigated the prevalence and effects of neutralizing autoantibodies against interleukin-1 receptor antagonist …
This multicenter randomized controlled trial evaluated the effects of immediate treatment versus deferred/no treatment for …
Obesity, the most common health problem in women of reproductive age, significantly increases risks for …
The PROMINENT trial assessed whether pemafibrate, a selective PPARα modulator could reduce cardiovascular events in …
This study analyzed the incidence of chronic kidney disease (CKD) among 654,459 adults with diabetes …
This multicenter, double blind, randomized, placebo-controlled trial investigated the cardiovascular effects of semaglutide in 17,604 …
This multicenter, randomized controlled trial investigated the effects of tight glucose control (target: 80–110 mg/dL) …
This phase 3 randomized controlled trial (SECURE) evaluated the efficacy of a cardiovascular polypill containing …
This registry-based analysis examined racial and ethnic disparities in the provision of bystander cardiopulmonary resuscitation …
The AMPLITUDE-O trial evaluated the cardiovascular and renal outcomes of efpeglenatide, a weekly glucagon-like peptide-1 …
